• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: September 30-October 4, 2013

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

September 30-October 4, 2013
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs9/30/13-10/4/13N/AN/AN/ANo Significant Meetings
John M. Taylor, III, Counselor to the Commissioner and Acting Deputy Commissioner for Global Regulatory Operations and Policy9/30/13-10/4/13N/AN/AN/ANo Significant Meetings
Virginia Cox, Associate Commissioner for External Affairs9/30/13-10/4/13N/AN/AN/ANo Significant Meetings
Elizabeth H. Dickinson, Esq., Chief Counsel9/30/13-10/4/13N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine9/30/13-10/4/13N/AN/AN/ANo Significant Meetings 
Jesse Goodman, M.D., M.P.H., Chief Scientist9/30/13-10/4/13N/AN/AN/ANo Significant Meetings
Walter S. Harris, M.B.A., P.M.P., Deputy Commissioner for Operations and Chief Operating Officer9/30/13-10/4/13N/AN/AN/ANo Significant Meetings
Sally Howard, J.D., Deputy Commisioner for Policy, Planning and Legislation and Acting Associate Commissioner for Legislation9/30/13-10/4/13N/AN/AN/ANo Significant Meetings
Michael M. Landa, J.D., Director, Center for Food Safety and Applied Nutrition9/30/13-10/4/13N/AN/AN/ANo Significant Meetings
Peter Lurie, M.D., M.P.H., Acting Associate Commissioner for Policy and Planning9/30/13Silver Spring, MDMichael Lanthier, Clark Nardinelli, Nellie Lew, Catherine Lorraine, Lisa DwyerMark Mathieu, Alberto Grignolo (PAREXEL)FDA Special Designations 
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research9/30/13-10/4/13N/AN/AN/ANo Significant Meetings
Melinda K. Plaiser, Associate Commissioner for Regulatory Affairs9/30/13-10/4/13N/AN/AN/ANo Significant Meetings
Jeffrey E. Shuren, M.D., J.D., Director, Center for Devices and Radiological Health9/30/13-10/4/13N/AN/AN/ANo Significant Meetings
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research9/30/13-10/4/13N/AN/AN/ANo Significant Meetings
Michael R. Taylor, J.D., Deputy Commissioner for Foods and Veterinary Medicine9/30/13-10/4/13N/AN/AN/ANo Significant Meetings
Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs9/30/13-10/4/13N/AN/AN/ANo Significant Meetings
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs9/30/13-10/4/13N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research9/30/13-10/4/13N/AN/AN/ANo Significant Meetings
Mitchell R. Zeller, J.D., Director, Center for Tobacco Products9/30/13-10/4/13N/AN/AN/ANo Significant Meetings